histamine has been researched along with Sarcoma, Kaposi in 4 studies
Sarcoma, Kaposi: A multicentric, malignant neoplastic vascular proliferation characterized by the development of bluish-red cutaneous nodules, usually on the lower extremities, most often on the toes or feet, and slowly increasing in size and number and spreading to more proximal areas. The tumors have endothelium-lined channels and vascular spaces admixed with variably sized aggregates of spindle-shaped cells, and often remain confined to the skin and subcutaneous tissue, but widespread visceral involvement may occur. Kaposi's sarcoma occurs spontaneously in Jewish and Italian males in Europe and the United States. An aggressive variant in young children is endemic in some areas of Africa. A third form occurs in about 0.04% of kidney transplant patients. There is also a high incidence in AIDS patients. (From Dorland, 27th ed & Holland et al., Cancer Medicine, 3d ed, pp2105-7) HHV-8 is the suspected cause.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The development of long-term culture of AIDS-KS cells has allowed us to investigate further a possible vascular origin of Kaposi sarcoma." | 5.28 | Active metabolism of arachidonic acid by Kaposi sarcoma cells cultured from lung biopsies (KS-3); identification by HPLC and MS/MS of the predominant metabolite secreted as the 11,12-epoxy-eicosatrienoic acid. ( Briquet, I; Deroussent, A; Dray, F; Gabellec, MM; Gouyette, A; Nakamura, S; Salahuddin, ZS; Vulliez-Le Normand, B; Wahl, LM, 1992) |
| "The development of long-term culture of AIDS-KS cells has allowed us to investigate further a possible vascular origin of Kaposi sarcoma." | 1.28 | Active metabolism of arachidonic acid by Kaposi sarcoma cells cultured from lung biopsies (KS-3); identification by HPLC and MS/MS of the predominant metabolite secreted as the 11,12-epoxy-eicosatrienoic acid. ( Briquet, I; Deroussent, A; Dray, F; Gabellec, MM; Gouyette, A; Nakamura, S; Salahuddin, ZS; Vulliez-Le Normand, B; Wahl, LM, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J | 2 |
| Song, J | 1 |
| Plaisance-Bonstaff, K | 1 |
| Mu, S | 1 |
| Post, SR | 2 |
| Dai, L | 2 |
| Qin, Z | 2 |
| Goldstein, A | 1 |
| Zhang, H | 1 |
| Tang, W | 1 |
| Forrest, JC | 1 |
| Chen, X | 1 |
| Dray, F | 1 |
| Vulliez-Le Normand, B | 1 |
| Deroussent, A | 1 |
| Briquet, I | 1 |
| Gabellec, MM | 1 |
| Nakamura, S | 1 |
| Wahl, LM | 1 |
| Gouyette, A | 1 |
| Salahuddin, ZS | 1 |
| Bhana, D | 1 |
| Hillier, K | 1 |
| Karim, SM | 1 |
4 other studies available for histamine and Sarcoma, Kaposi
| Article | Year |
|---|---|
Role of Histamine and Related Signaling in Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis and Oncogenesis.
Topics: Animals; Carcinogenesis; Cell Transformation, Neoplastic; Herpesvirus 8, Human; Histamine; Humans; M | 2023 |
Identification of new antiviral agents against Kaposi's sarcoma-associated herpesvirus (KSHV) by high-throughput drug screening reveals the role of histamine-related signaling in promoting viral lytic reactivation.
Topics: Antiviral Agents; Drug Evaluation, Preclinical; Herpesvirus 8, Human; High-Throughput Screening Assa | 2019 |
Active metabolism of arachidonic acid by Kaposi sarcoma cells cultured from lung biopsies (KS-3); identification by HPLC and MS/MS of the predominant metabolite secreted as the 11,12-epoxy-eicosatrienoic acid.
Topics: 8,11,14-Eicosatrienoic Acid; Acquired Immunodeficiency Syndrome; Arachidonic Acid; Biopsy; Cells, Cu | 1992 |
Vasoactive substances in Kaposi's sarcoma.
Topics: Animals; Arm; Chromatography, Thin Layer; Diarrhea; Guinea Pigs; Histamine; Humans; Hydroxyindoleace | 1971 |